TP53 and neoplasm: Plasma serial monitoring for individual tumor mutations in TP53, PIK3CA, GATA3, ARID1A, AKT which are the most commonly found altered genes in breast cancer (11–13), has shown to detect minimal residual disease even months before clinical or radiologic evidence of overt metastases (14–16).